According to a new research report, women who have been taking a low-dose of aspirin regularly may have a lower risk of ovarian cancer. The study showcases two important caveats. However, regular usage of standard-dose aspirin amounting to 325 milligrams daily does not affect much. Additionally, a heavy consumption of nonaspirin nonsteroidal anti-inflammatories (NSAIDs), namely ibuprofen as well as naproxen, might even increase your risk of getting affected. The study was published recently in a reputed medical journal.
One of the potential limitations of the report is that the lower risk of the disease was found among women, especially who had been consuming a lower dose of aspirin for a period for less than a year.
Ovarian cancer ranks fifth in the list of the most common causes of cancer-related deaths for American women. The authors of the report suggest that consumption of aspirin in a lower dosage is found to reduce inflammation. This groundbreaking analysis has taken into account the data collected from 205,498 women. These women had been a part of the ‘Nurses’ Health Study I and II’. These are two of the long-term research operations that used specific sets of questions to monitor diseases and track health behaviour among women.
Among the 205,498 women associated with the research, 1,054 of them had developed traces of ovarian cancer. The research team was able to examine the level of aspirin these women used. The report also took into consideration the daily intake of non-aspirin NSAIDs as well as acetaminophen. The researchers compared the women’s behaviour with other participants, based on their medicinal dependence.
According to the final analysis, women who continued taking a low-dose of aspirin over the course of less than one year were exposed to 23% lower risk of cancer as compared to those who never used aspirin at all. Nevertheless, the research also shows that women who took a low-dose aspirin for a period of five years or more, failed to show any improvement in their odds of getting affected by ovarian cancer. In addition, women who used a standard-dose of aspirin, or 325 milligrams regularly were found to have a similar result.
In contrast, consuming non-aspirin NSAIDs regularly for even less than a year showed an increase in the risk of developing cancer, by almost 19%. The researchers at the Harvard T.H. Chan School of Public Health have noticed this threat.